ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.720
-0.140 (-4.90%)
At close: Sep 18, 2025, 4:00 PM EDT
2.720
0.00 (0.00%)
After-hours: Sep 18, 2025, 4:00 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $62.73 million as of September 18, 2025. Its market cap has increased by 646.79% in one year.
Market Cap
62.73M
Enterprise Value
66.96M
1-Year Change
646.79%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $62.73M, a decrease of -21.09%. That is a compound annual growth rate of -5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 67.30M | 774.03% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |